首页 > 最新文献

Integrated Pharmacy Research and Practice最新文献

英文 中文
The Role of the Pharmacist in the Care of Patients with Chronic Pain. 药剂师在慢性疼痛患者护理中的作用。
IF 2.9 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2021-04-30 eCollection Date: 2021-01-01 DOI: 10.2147/IPRP.S248699
Laura Murphy, Karen Ng, Pearl Isaac, Jaris Swidrovich, Maria Zhang, Beth A Sproule

Pharmacists across the healthcare continuum are well positioned to collaborate with patients to effectively manage their chronic pain. Evidence supports positive outcomes when pharmacists undertake these roles; however, there are barriers preventing uptake across the profession. This paper aims to expand awareness of the breadth of these roles, including pharmaceutical care provision, interprofessional collaboration, pain and medication education, support for patients in self-management and acceptance of responsibility to be culturally responsive and decrease stigma. Pharmacists are accessible healthcare professionals and can improve the care of patients with chronic pain.

在整个医疗保健过程中,药剂师完全有能力与患者合作,有效控制他们的慢性疼痛。有证据表明,药剂师在发挥这些作用时会产生积极的结果;然而,在整个行业中,药剂师在发挥这些作用时会遇到一些障碍。本文旨在提高人们对这些角色的广泛性的认识,包括提供药物护理、跨专业合作、疼痛和药物教育、支持患者进行自我管理以及承担责任,以适应文化差异并减少耻辱感。药剂师是可以接触到的医疗保健专业人员,可以改善对慢性疼痛患者的护理。
{"title":"The Role of the Pharmacist in the Care of Patients with Chronic Pain.","authors":"Laura Murphy, Karen Ng, Pearl Isaac, Jaris Swidrovich, Maria Zhang, Beth A Sproule","doi":"10.2147/IPRP.S248699","DOIUrl":"10.2147/IPRP.S248699","url":null,"abstract":"<p><p>Pharmacists across the healthcare continuum are well positioned to collaborate with patients to effectively manage their chronic pain. Evidence supports positive outcomes when pharmacists undertake these roles; however, there are barriers preventing uptake across the profession. This paper aims to expand awareness of the breadth of these roles, including pharmaceutical care provision, interprofessional collaboration, pain and medication education, support for patients in self-management and acceptance of responsibility to be culturally responsive and decrease stigma. Pharmacists are accessible healthcare professionals and can improve the care of patients with chronic pain.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"10 ","pages":"33-41"},"PeriodicalIF":2.9,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6b/a2/iprp-10-33.PMC8096635.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38958000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Collaborative Medication Reviews to Identify Inappropriate Prescribing in Pre-Admission Medications at Emergency Department Short-Term Ward. 通过合作用药审查,识别急诊科短期病房入院前用药的不当处方。
IF 2.9 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2021-04-22 eCollection Date: 2021-01-01 DOI: 10.2147/IPRP.S280523
Ercan Celikkayalar, Juha Puustinen, Joni Palmgren, Marja Airaksinen

Purpose: Collaborative medication reviews (CMR) have been shown to reduce inappropriate prescribing (IP) in various settings. This study aimed at describing a CMR practice in an emergency department (ED) short-term ward in Finland to investigate IP in pre-admission medications.

Patients and methods: Pre-admission medications were collaboratively reviewed for all the adult ED admissions within a 5-month study period in 2016. Types of IP were inductively categorized, and descriptive statistics were used to show the incidence and type of IP events.

Results: The pre-admission medications of 855 adult ED patients were reviewed by the pharmacist, with 113 IP events identified in 83 (9.7%) of the patients. The majority (81%, n=67) of these patients were older adults (≥65 years). Of these 94 IP events identified in 67 older patients, 58 (62%) were confirmed by the ED physicians. The following 3 main categories were inductively developed for the types of identified and confirmed IP events: 1) Misprescribing (prescription of medications that significantly increase the risk of adverse drug events); 2) Overprescribing (prescription of medications for which no clear clinical indications exist); and 3) Underprescribing (omission of potentially beneficial medications that are clinically indicated for treatment or prevention of a disease). Misprescribing was the most common type of IP identified (79% of the identified and 72% confirmed IP events). Benzodiazepines (29%) and antidepressants (28%) were involved in 33 out of 58 (57%) confirmed IP events. Medications with strong anticholinergic effects were involved in 19% of the confirmed IP events.

Conclusion: The CMR practice was able to identify IP in pre-admission medications of about one-tenth of ED patients. Older patients using benzodiazepines and drugs with strong anticholinergic effects should be paid special attention to ED admissions.

目的:合作用药审查(CMR)已被证明可减少各种情况下的不当处方(IP)。本研究旨在描述芬兰一家急诊科(ED)短期病房的CMR实践,以调查入院前用药的IP情况:在 2016 年为期 5 个月的研究期间,对急诊科所有入院成人的入院前用药进行了合作审查。对IP类型进行归纳分类,并使用描述性统计来显示IP事件的发生率和类型:药剂师对 855 名成人急诊患者的入院前用药进行了审查,在 83 名患者(9.7%)中发现了 113 例 IP 事件。这些患者中的大多数(81%,n=67)是老年人(≥65 岁)。在 67 名老年患者中发现的 94 例 IP 事件中,有 58 例(62%)得到了急诊科医生的确认。根据已发现和确认的 IP 事件类型,归纳出以下 3 个主要类别:1) 错开处方(开具会显著增加药物不良事件风险的药物处方);2) 处方过多(开具无明确临床适应症的药物处方);3) 处方过少(遗漏开具临床上适用于治疗或预防疾病的潜在有益药物处方)。开错处方是最常见的 IP 类型(占已发现 IP 事件的 79%,占已确认 IP 事件的 72%)。在 58 例确认的 IP 事件中,有 33 例(57%)涉及苯二氮卓类药物(29%)和抗抑郁药物(28%)。在19%的确诊IP事件中,涉及具有强烈抗胆碱能作用的药物:CMR实践能够在约十分之一的急诊患者入院前的用药中发现IP。使用苯二氮卓类药物和具有强烈抗胆碱能作用的药物的老年患者在急诊入院时应受到特别关注。
{"title":"Collaborative Medication Reviews to Identify Inappropriate Prescribing in Pre-Admission Medications at Emergency Department Short-Term Ward.","authors":"Ercan Celikkayalar, Juha Puustinen, Joni Palmgren, Marja Airaksinen","doi":"10.2147/IPRP.S280523","DOIUrl":"10.2147/IPRP.S280523","url":null,"abstract":"<p><strong>Purpose: </strong>Collaborative medication reviews (CMR) have been shown to reduce inappropriate prescribing (IP) in various settings. This study aimed at describing a CMR practice in an emergency department (ED) short-term ward in Finland to investigate IP in pre-admission medications.</p><p><strong>Patients and methods: </strong>Pre-admission medications were collaboratively reviewed for all the adult ED admissions within a 5-month study period in 2016. Types of IP were inductively categorized, and descriptive statistics were used to show the incidence and type of IP events.</p><p><strong>Results: </strong>The pre-admission medications of 855 adult ED patients were reviewed by the pharmacist, with 113 IP events identified in 83 (9.7%) of the patients. The majority (81%, n=67) of these patients were older adults (≥65 years). Of these 94 IP events identified in 67 older patients, 58 (62%) were confirmed by the ED physicians. The following 3 main categories were inductively developed for the types of identified and confirmed IP events: 1) Misprescribing (prescription of medications that significantly increase the risk of adverse drug events); 2) Overprescribing (prescription of medications for which no clear clinical indications exist); and 3) Underprescribing (omission of potentially beneficial medications that are clinically indicated for treatment or prevention of a disease). Misprescribing was the most common type of IP identified (79% of the identified and 72% confirmed IP events). Benzodiazepines (29%) and antidepressants (28%) were involved in 33 out of 58 (57%) confirmed IP events. Medications with strong anticholinergic effects were involved in 19% of the confirmed IP events.</p><p><strong>Conclusion: </strong>The CMR practice was able to identify IP in pre-admission medications of about one-tenth of ED patients. Older patients using benzodiazepines and drugs with strong anticholinergic effects should be paid special attention to ED admissions.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"10 ","pages":"23-32"},"PeriodicalIF":2.9,"publicationDate":"2021-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/21/d7/iprp-10-23.PMC8075306.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38919301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Considering the Potential Benefits of Over-the-Counter Naloxone. 考虑到非处方纳洛酮的潜在益处。
IF 2.9 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2021-02-15 eCollection Date: 2021-01-01 DOI: 10.2147/IPRP.S244709
Kirk E Evoy, Lucas G Hill, Corey S Davis

Since 1999, annual opioid-related overdose (ORO) mortality has increased more than six-fold. In response to this crisis, the US Department of Health and Human Services outlined a 5-point strategy to reduce ORO mortality which included the widespread distribution of naloxone, an opioid antagonist that can rapidly reverse an opioid overdose. Increased distribution has been facilitated by the implementation of naloxone access laws in each US state aimed at increasing community access to naloxone. While these laws differ from state-to-state, most contain mechanisms to enable pharmacists to dispense naloxone without a patient-specific prescription. These laws have enhanced community naloxone distribution, both from pharmacies and overdose education and naloxone distribution programs, and produced positive effects on ORO mortality. However, a growing body of evidence has revealed that significant barriers to naloxone access from pharmacies remain, and annual ORO deaths have continued to climb. Given these concerns, there has been a push among some clinicians and policymakers for the US Food and Drug Administration to re-classify naloxone as an over-the-counter (OTC) medication as a means to further increase its accessibility. If an OTC transition occurs, educational outreach and funding for clinical innovations will continue to be crucial given the important role of health professionals in recommending naloxone to people at risk for experiencing or witnessing an ORO. Recognizing the severity of the ORO public health crisis, we believe transitioning formulations of naloxone approved for layperson use to OTC status would result in a net benefit through increased access. However, such a change should be combined with measures to ensure affordability.

自1999年以来,每年与阿片类药物有关的过量(ORO)死亡率增加了六倍多。为了应对这一危机,美国卫生与公众服务部概述了降低ORO死亡率的五点战略,其中包括广泛分发纳洛酮,这是一种阿片类药物拮抗剂,可以迅速逆转阿片类药物过量。在美国各州实施纳洛酮获取法,旨在增加社区对纳洛酮的获取,从而促进了分发的增加。虽然这些法律因州而异,但大多数都包含使药剂师能够在没有患者特定处方的情况下配发纳洛酮的机制。这些法律加强了社区纳洛酮的分发,包括药房和过量教育以及纳洛酮分发计划,并对ORO死亡率产生了积极影响。然而,越来越多的证据表明,从药店获得纳洛酮仍然存在重大障碍,每年因ORO死亡的人数继续攀升。鉴于这些担忧,一些临床医生和政策制定者一直在推动美国食品和药物管理局将纳洛酮重新归类为非处方药(OTC),以进一步增加其可及性。如果发生OTC过渡,鉴于卫生专业人员在向有经历或目睹ORO风险的人推荐纳洛酮方面的重要作用,教育宣传和临床创新资金将继续至关重要。认识到ORO公共卫生危机的严重性,我们认为将批准用于外行人的纳洛酮制剂转变为OTC将通过增加获取而产生净收益。但是,这种改变应与确保负担能力的措施结合起来。
{"title":"Considering the Potential Benefits of Over-the-Counter Naloxone.","authors":"Kirk E Evoy,&nbsp;Lucas G Hill,&nbsp;Corey S Davis","doi":"10.2147/IPRP.S244709","DOIUrl":"https://doi.org/10.2147/IPRP.S244709","url":null,"abstract":"<p><p>Since 1999, annual opioid-related overdose (ORO) mortality has increased more than six-fold. In response to this crisis, the US Department of Health and Human Services outlined a 5-point strategy to reduce ORO mortality which included the widespread distribution of naloxone, an opioid antagonist that can rapidly reverse an opioid overdose. Increased distribution has been facilitated by the implementation of naloxone access laws in each US state aimed at increasing community access to naloxone. While these laws differ from state-to-state, most contain mechanisms to enable pharmacists to dispense naloxone without a patient-specific prescription. These laws have enhanced community naloxone distribution, both from pharmacies and overdose education and naloxone distribution programs, and produced positive effects on ORO mortality. However, a growing body of evidence has revealed that significant barriers to naloxone access from pharmacies remain, and annual ORO deaths have continued to climb. Given these concerns, there has been a push among some clinicians and policymakers for the US Food and Drug Administration to re-classify naloxone as an over-the-counter (OTC) medication as a means to further increase its accessibility. If an OTC transition occurs, educational outreach and funding for clinical innovations will continue to be crucial given the important role of health professionals in recommending naloxone to people at risk for experiencing or witnessing an ORO. Recognizing the severity of the ORO public health crisis, we believe transitioning formulations of naloxone approved for layperson use to OTC status would result in a net benefit through increased access. However, such a change should be combined with measures to ensure affordability.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"10 ","pages":"13-21"},"PeriodicalIF":2.9,"publicationDate":"2021-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0f/e8/iprp-10-13.PMC7894851.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25399250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Evaluation of Pharmaceuticals Inventory Management in Selected Health Facilities of West Arsi Zone, Oromia, Ethiopia. 埃塞俄比亚奥罗莫州西阿尔西区部分医疗机构药品库存管理评估。
IF 2.9 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2021-02-09 eCollection Date: 2021-01-01 DOI: 10.2147/IPRP.S298660
Tadesse Jobira, Habtamu Abuye, Awol Jemal, Tadesse Gudeta

Background: Effective inventory management ensures an uninterrupted supply of safe, effective, and affordable pharmaceuticals which could be achieved through developing ABC-VEN (Always, Better, Control-Vital, Essential, Desirable) and FSN-XYZ (Fast, Slow, Non-moving-High, Medium, Low Value) matrix analysis. ABC-VEN matrix analysis is used to control inventory according to their annual consumption and on their functional importance whereas, FSN-XYZ matrix analysis is applied to control inventory by identifying the items to be discarded and the amount saved during the closing of annual accounts.

Objective: To evaluate inventory management in selected health facilities of West Arsi zone, Oromia regional state for the year 2016-2018.

Methods: Facility-based cross-sectional descriptive study complemented with a qualitative study was conducted in fourteen health facilities. Data were collected from goods issuing vouchers for the year 2016-2018 to perform ABC-VEN matrix analysis. The frequency of issue was collected to perform FSN analysis and the value of each closing stock was taken to get XYZ analysis.

Results: From the ABC-VEN matrix analysis, 26.6% of items were Category I of which the highest proportion were taken by class A and V items consuming 84.7% of annual drug expenditure (ADE). The remaining 49.2% and 24.2% of the drugs accounted for only 13.2% and 2.1% of the ADE being category II and III, respectively. Based on FSN-XYZ matrix analysis findings, category I with 41.% item share account for the highest budget (average 86.5% of values). Of this category, the XN group-non-moving and high-cost drugs had the high value (20%) which need managerial measure. In category III, the ZN group items, being 25% of drugs, only had 2.2% of value-that may increase wastage, inventory holding cost, and shortage of storage space.

Conclusion: The matrix analysis for inventory control is a strong tool that enables one to identify items requiring close monitoring. The coupled ABC-VEN matrix analysis, combining their individual advantages - inventory's cost and its functional importance help in achieving a meaningful inventory management. However, to control the stock at an appropriate level with minimum shortage and oversupply, it has to be supported by XYZ-FSN matrix analysis. The XYZ-FSN matrix benefits the health facilities to determine the level of inventory with high value in dead-stock, and to take measures like transferring to others, discarding, or saving.

背景:有效的库存管理可确保不间断地供应安全、有效和价格合理的药品,这可以通过开发 ABC-VEN(始终、更好、控制-重要、必要、理想)和 FSN-XYZ(快速、缓慢、不动-高、中、低价值)矩阵分析来实现。ABC-VEN 矩阵分析法用于根据库存的年消耗量及其功能重要性来控制库存,而 FSN-XYZ 矩阵分析法则通过确定应丢弃的物品和年度结账时节省的金额来控制库存:评估奥罗米亚州西阿尔西区部分医疗机构 2016-2018 年的库存管理情况:在 14 家医疗机构中开展了以医疗机构为基础的横断面描述性研究,并辅以定性研究。收集了 2016-2018 年货物发放凭证的数据,以进行 ABC-VEN 矩阵分析。收集发放频率以进行FSN分析,提取每笔期末存货的价值以进行XYZ分析:根据 ABC-VEN 矩阵分析,26.6% 的药品属于第一类,其中占比最高的是 A 类和 V 类药品,占年度药品支出(ADE)的 84.7%。其余 49.2%和 24.2%的药品分别只占第二类和第三类 ADE 的 13.2%和 2.1%。根据 FSN-XYZ 矩阵分析结果,第 I 类药品的预算最高(平均占总值的 86.5%),占 41.%。在这一类中,XN 组--非移动和高成本药品的价值最高(20%),需要采取管理措施。在第三类中,ZN 组药品占 25%,但价值仅占 2.2%,这可能会增加浪费、库存持有成本和存储空间短缺:用于库存控制的矩阵分析是一种强有力的工具,能帮助人们确定需要密切监控的物品。ABC-VEN 矩阵分析结合了各自的优势--库存成本及其功能重要性,有助于实现有意义的库存管理。然而,要将库存控制在适当的水平,将短缺和供应过剩降至最低,还必须辅以 XYZ-FSN 矩阵分析。XYZ-FSN 矩阵有利于卫生机构确定死库存中价值较高的库存水平,并采取转移、丢弃或保存等措施。
{"title":"Evaluation of Pharmaceuticals Inventory Management in Selected Health Facilities of West Arsi Zone, Oromia, Ethiopia.","authors":"Tadesse Jobira, Habtamu Abuye, Awol Jemal, Tadesse Gudeta","doi":"10.2147/IPRP.S298660","DOIUrl":"10.2147/IPRP.S298660","url":null,"abstract":"<p><strong>Background: </strong>Effective inventory management ensures an uninterrupted supply of safe, effective, and affordable pharmaceuticals which could be achieved through developing ABC-VEN (Always, Better, Control-Vital, Essential, Desirable) and FSN-XYZ (Fast, Slow, Non-moving-High, Medium, Low Value) matrix analysis. ABC-VEN matrix analysis is used to control inventory according to their annual consumption and on their functional importance whereas, FSN-XYZ matrix analysis is applied to control inventory by identifying the items to be discarded and the amount saved during the closing of annual accounts.</p><p><strong>Objective: </strong>To evaluate inventory management in selected health facilities of West Arsi zone, Oromia regional state for the year 2016-2018.</p><p><strong>Methods: </strong>Facility-based cross-sectional descriptive study complemented with a qualitative study was conducted in fourteen health facilities. Data were collected from goods issuing vouchers for the year 2016-2018 to perform ABC-VEN matrix analysis. The frequency of issue was collected to perform FSN analysis and the value of each closing stock was taken to get XYZ analysis.</p><p><strong>Results: </strong>From the ABC-VEN matrix analysis, 26.6% of items were Category I of which the highest proportion were taken by class A and V items consuming 84.7% of annual drug expenditure (ADE). The remaining 49.2% and 24.2% of the drugs accounted for only 13.2% and 2.1% of the ADE being category II and III, respectively. Based on FSN-XYZ matrix analysis findings, category I with 41.% item share account for the highest budget (average 86.5% of values). Of this category, the XN group-non-moving and high-cost drugs had the high value (20%) which need managerial measure. In category III, the ZN group items, being 25% of drugs, only had 2.2% of value-that may increase wastage, inventory holding cost, and shortage of storage space.</p><p><strong>Conclusion: </strong>The matrix analysis for inventory control is a strong tool that enables one to identify items requiring close monitoring. The coupled ABC-VEN matrix analysis, combining their individual advantages - inventory's cost and its functional importance help in achieving a meaningful inventory management. However, to control the stock at an appropriate level with minimum shortage and oversupply, it has to be supported by XYZ-FSN matrix analysis. The XYZ-FSN matrix benefits the health facilities to determine the level of inventory with high value in dead-stock, and to take measures like transferring to others, discarding, or saving.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"10 ","pages":"1-11"},"PeriodicalIF":2.9,"publicationDate":"2021-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8b/7a/iprp-10-1.PMC7882713.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25382519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patients' Attitudes, Awareness, and Opinions About Community Pharmacies in Japan: Next Steps for the Health Support Pharmacy System. 日本患者对社区药房的态度、意识和意见:健康支持药房系统的下一步。
IF 2.9 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2020-11-12 eCollection Date: 2020-01-01 DOI: 10.2147/IPRP.S275288
Noritake Hirota, Noboru Okamura

Purpose: Despite the formal establishment of the Health Support Pharmacy system, few community pharmacies have transitioned to this new designation in Japan. Moreover, patients' perspectives on the usefulness of health-support pharmacies and community pharmacies have not yet been investigated. In this work, we investigated patients' attitudes, opinions, and awareness as users of member pharmacies of the Japan Federation of Democratic Medical Institutions (Min-Iren), with respect to two essential functions provided by community pharmacies-primary care and health support-to identify modern challenges facing community pharmacies.

Methods: Regular visitors to participating Min-Iren community pharmacies were asked to complete an anonymous questionnaire. Responses were compared between users of health-support pharmacies and other pharmacy types, as well as between members and non-members of "collaborating organizations" (CO). CO is organizational partners of Min-Iren whose activities support affiliated facilities. Logistic regression analysis was performed to explore the predictive value of different factors on pharmacies' primary-care and health-support functionality.

Results: A total of 181 Min-Iren community pharmacies (51.7%: 181/350) participated in this study, and most patients answered the questionnaire (97.7%, n=2623). Relatively few patients recognized the term "Health Support Pharmacy" (12.2%). CO members tended to have a superior understanding of a wide variety of services provided by CPs as compared to non-members. Statistically significant predictors of primary-care and health-support functionality included male gender, having a primary-care pharmacist, age ≥60 years, recognition of the term "Health Support Pharmacy" and CO membership.

Conclusion: CO members, a class of patients with a superior awareness of health promotion, demonstrated a good understanding of the variety of services provided by community pharmacies and tended to positively rate their pharmacy. Moving forward, efforts to raise awareness about the importance of health-promotional activities among community pharmacy users should further reinforce the primary-care and health-support functions of community pharmacies.

目的:尽管正式建立了卫生支持药房系统,但在日本,很少有社区药房过渡到这个新名称。此外,尚未调查患者对健康支持药房和社区药房有用性的看法。在这项工作中,我们调查了患者作为日本民主医疗机构联合会(Min-Iren)成员药房用户的态度、意见和意识,涉及社区药房提供的两项基本功能——初级保健和卫生支持——以确定社区药房面临的现代挑战。方法:对常住居民社区药房的顾客进行匿名问卷调查。对保健支助药房的使用者与其他类型药房的使用者之间以及"合作组织"的成员与非成员之间的答复进行了比较。CO是Min-Iren的组织伙伴,其活动支持附属设施。采用Logistic回归分析,探讨不同因素对药店初级保健和健康支持功能的预测价值。结果:共有181家民医社区药房(51.7%:181/350)参与了本研究,大部分患者回答了问卷(97.7%,n=2623)。认识“健康支持药房”一词的患者相对较少(12.2%)。与非会员相比,文书主任成员对CPs提供的各种服务往往有更深入的了解。初级保健和卫生支持功能的统计显著预测因素包括男性、拥有初级保健药剂师、年龄≥60岁、认识“卫生支持药房”一词和CO会员资格。结论:社区药房成员是健康促进意识较强的一类患者,对社区药房提供的各种服务有较好的了解,并倾向于对其药房给予积极评价。今后,努力提高社区药房使用者对促进健康活动重要性的认识,应进一步加强社区药房的初级保健和健康支持功能。
{"title":"Patients' Attitudes, Awareness, and Opinions About Community Pharmacies in Japan: Next Steps for the Health Support Pharmacy System.","authors":"Noritake Hirota,&nbsp;Noboru Okamura","doi":"10.2147/IPRP.S275288","DOIUrl":"https://doi.org/10.2147/IPRP.S275288","url":null,"abstract":"<p><strong>Purpose: </strong>Despite the formal establishment of the Health Support Pharmacy system, few community pharmacies have transitioned to this new designation in Japan. Moreover, patients' perspectives on the usefulness of health-support pharmacies and community pharmacies have not yet been investigated. In this work, we investigated patients' attitudes, opinions, and awareness as users of member pharmacies of the Japan Federation of Democratic Medical Institutions (Min-Iren), with respect to two essential functions provided by community pharmacies-primary care and health support-to identify modern challenges facing community pharmacies.</p><p><strong>Methods: </strong>Regular visitors to participating Min-Iren community pharmacies were asked to complete an anonymous questionnaire. Responses were compared between users of health-support pharmacies and other pharmacy types, as well as between members and non-members of \"collaborating organizations\" (CO). CO is organizational partners of Min-Iren whose activities support affiliated facilities. Logistic regression analysis was performed to explore the predictive value of different factors on pharmacies' primary-care and health-support functionality.</p><p><strong>Results: </strong>A total of 181 Min-Iren community pharmacies (51.7%: 181/350) participated in this study, and most patients answered the questionnaire (97.7%, n=2623). Relatively few patients recognized the term \"Health Support Pharmacy\" (12.2%). CO members tended to have a superior understanding of a wide variety of services provided by CPs as compared to non-members. Statistically significant predictors of primary-care and health-support functionality included male gender, having a primary-care pharmacist, age ≥60 years, recognition of the term \"Health Support Pharmacy\" and CO membership.</p><p><strong>Conclusion: </strong>CO members, a class of patients with a superior awareness of health promotion, demonstrated a good understanding of the variety of services provided by community pharmacies and tended to positively rate their pharmacy. Moving forward, efforts to raise awareness about the importance of health-promotional activities among community pharmacy users should further reinforce the primary-care and health-support functions of community pharmacies.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"9 ","pages":"243-256"},"PeriodicalIF":2.9,"publicationDate":"2020-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/IPRP.S275288","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38617684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Medication-Related Needs and Humanistic Impact of Patient-Centered Pharmaceutical Care at University of Gondar Comprehensive Specialized Hospital, North-West Ethiopia. 埃塞俄比亚西北部贡达尔大学综合专科医院以患者为中心的药学服务的药物相关需求和人文影响
IF 2.9 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2020-11-06 eCollection Date: 2020-01-01 DOI: 10.2147/IPRP.S268248
Ousman Abubeker Abdela, Enathun Abay, Senait Beka, Biset Mengistie, Mohammed Biset Ayalew

Purpose: To assess patients' medication-related needs and the humanistic impact of patient-centered pharmaceutical care.

Patients and methods: A hospital-based cross-sectional study was conducted using self-administered structured questionnaires from February 4 to 28, 2019, on patients attending ambulatory care for chronic non-communicable diseases at the University of Gondar specialized teaching hospital, North-west Ethiopia. Data were entered to SPSS version 22 for analysis. Descriptive statistics was used to describe the socio-demographic characteristics and medication-related needs of study participants. Independent sample t-test and one-way ANOVA analysis were performed to check for possible associations between dependent and independent variables.

Results: Information about what to do if patients missed doses and the potential side-effects or abnormal conditions caused by the prescribed medicines were not explained for most of the 425 patients studied. The majority of the study participants reported that they felt worried about adverse medicine effects, drug interactions, and long-term medicine use. Patients who were older than 50 or those receiving two or more medications were less satisfied with the effect of their medicine as compared to younger ones and those on monotherapy, respectively. People who were illiterate or had attended only primary schools thought that they received less disease and medicine information from health professionals than people who attended tertiary education.

Conclusion and recommendation: Most of the participants were particularly unhappy with the amount of information received about side-effects and what to do if doses were missed. Special emphasis should be given to patients with a low level of education as they were not satisfied with medicine and disease information obtained from health professionals, experienced more psychological impacts of medicine use, and had poor overall quality-of-life.

目的:评估患者用药需求及以患者为中心的药学服务的人文影响。患者和方法:2019年2月4日至28日,对埃塞俄比亚西北部贡达尔大学专业教学医院慢性非传染性疾病门诊患者进行了一项基于医院的横断面研究,采用自我管理的结构化问卷。数据输入SPSS version 22进行分析。描述性统计用于描述研究参与者的社会人口学特征和药物相关需求。采用独立样本t检验和单因素方差分析检验因变量和自变量之间可能存在的关联。结果:在研究的425名患者中,大多数人都没有解释如果患者错过剂量该怎么办,以及处方药物引起的潜在副作用或异常情况。大多数研究参与者报告说,他们对药物不良反应、药物相互作用和长期用药感到担忧。年龄超过50岁的患者或接受两种或两种以上药物治疗的患者对药物效果的满意度分别低于年轻患者和接受单一治疗的患者。文盲或只上过小学的人认为,与受过高等教育的人相比,他们从卫生专业人员那里获得的疾病和医学信息较少。结论和建议:大多数参与者对收到的关于副作用的信息以及如果错过剂量该怎么办的信息特别不满意。应特别重视受教育程度低的患者,因为他们对从卫生专业人员那里获得的药物和疾病信息不满意,用药的心理影响更大,总体生活质量较差。
{"title":"Medication-Related Needs and Humanistic Impact of Patient-Centered Pharmaceutical Care at University of Gondar Comprehensive Specialized Hospital, North-West Ethiopia.","authors":"Ousman Abubeker Abdela,&nbsp;Enathun Abay,&nbsp;Senait Beka,&nbsp;Biset Mengistie,&nbsp;Mohammed Biset Ayalew","doi":"10.2147/IPRP.S268248","DOIUrl":"https://doi.org/10.2147/IPRP.S268248","url":null,"abstract":"<p><strong>Purpose: </strong>To assess patients' medication-related needs and the humanistic impact of patient-centered pharmaceutical care.</p><p><strong>Patients and methods: </strong>A hospital-based cross-sectional study was conducted using self-administered structured questionnaires from February 4 to 28, 2019, on patients attending ambulatory care for chronic non-communicable diseases at the University of Gondar specialized teaching hospital, North-west Ethiopia. Data were entered to SPSS version 22 for analysis. Descriptive statistics was used to describe the socio-demographic characteristics and medication-related needs of study participants. Independent sample <i>t</i>-test and one-way ANOVA analysis were performed to check for possible associations between dependent and independent variables.</p><p><strong>Results: </strong>Information about what to do if patients missed doses and the potential side-effects or abnormal conditions caused by the prescribed medicines were not explained for most of the 425 patients studied. The majority of the study participants reported that they felt worried about adverse medicine effects, drug interactions, and long-term medicine use. Patients who were older than 50 or those receiving two or more medications were less satisfied with the effect of their medicine as compared to younger ones and those on monotherapy, respectively. People who were illiterate or had attended only primary schools thought that they received less disease and medicine information from health professionals than people who attended tertiary education.</p><p><strong>Conclusion and recommendation: </strong>Most of the participants were particularly unhappy with the amount of information received about side-effects and what to do if doses were missed. Special emphasis should be given to patients with a low level of education as they were not satisfied with medicine and disease information obtained from health professionals, experienced more psychological impacts of medicine use, and had poor overall quality-of-life.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"9 ","pages":"229-242"},"PeriodicalIF":2.9,"publicationDate":"2020-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/IPRP.S268248","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38604640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of Medicine-Use Pattern Using World Health Organization's Core Drug-Use Indicators and Completeness of Prescription at University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia: Cross-Sectional Study. 埃塞俄比亚贡达尔贡达尔大学综合专科医院使用世界卫生组织核心用药指标和处方完整性的用药模式评价:横断面研究
IF 2.9 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-23 eCollection Date: 2020-01-01 DOI: 10.2147/IPRP.S261320
Kefyalew Ayalew Getahun, Adugnaw Sitotie Redia, Tezera Jemere Aragaw

Background: Rational use of medicines is patients receiving medicines appropriate to their diagnosis in doses that meet their requirements for an adequate period of time at an affordable price. Irrational prescribing practices result in ineffective, unsafe treatment, prolong prognosis, and increase health-care costs, and this is a common phenomenon in Ethiopia. The aim of this study was to evaluate medicine-use pattern using World Health Organization core drug-use indicators and completeness of prescription at the University of Gondar Comprehensive Specialized Hospital.

Methods: A retrospective and prospective cross-sectional descriptive study was conducted at the dispensing pharmacy units of the health facility from March 2019 to May 2019 using a systematic random sampling technique. Data were analyzed using SPSS version 24.0, and results are presented using tables.

Results: A total of 1,128 medicines were covered in the analyzed sample. The response rate, using standard prescription paper was found to be 100%. Mean number of medicines per prescription was 1.88. The proportion of medicines actually dispensed was 74.56%, and 91.4% medicines were prescribed by their generic names. Among prescribed medicines, antibiotics accounted for 37.5%, and 20% of the prescribed medicines were injectable. Prescriptions containing patient name, identification number, age, and sex comprised 99.8%, 99.5%, 91.8%, and 94.5%, respectively of the total. Prescriptions signed by prescribers accounted for 96.2%, however, only 75.8% of prescribers wrote their name. Moreover, only 4.8% of dispensers printed their name, and 32.7% of prescriptions were signed by pharmacists. Patient-care indicators were found to be below standard.

Conclusion: Most prescriptions were incomplete, and prescribers by far completed their role than dispensers. The health facility has standard prescription paper and updated pharmaceuticals list. Percentages for encounters with antibiotics, prescribing by generic name, and patient-care indicators deviated from the standard. The dispensing and counseling time also far from the standard, and most medicines were not labeled.

背景:合理用药是指患者在足够的时间内以可承受的价格以满足其需求的剂量接受适合其诊断的药物。不合理的处方做法导致无效、不安全的治疗,延长预后,并增加保健费用,这是埃塞俄比亚的一个普遍现象。本研究的目的是利用世界卫生组织的核心用药指标和处方的完整性来评价贡达尔大学综合专科医院的用药模式。方法:采用系统随机抽样技术,于2019年3月至2019年5月在该卫生机构的调剂药房进行回顾性和前瞻性横断面描述性研究。数据分析采用SPSS 24.0版本,结果以表格形式呈现。结果:分析样本共包含1128种药物。使用标准处方纸的反应率为100%。每张处方的平均药品数为1.88种。药品实际配发比例为74.56%,其中91.4%的药品使用仿制名处方。在处方药中,抗生素占37.5%,注射剂占20%。包含患者姓名、身份证号、年龄和性别的处方分别占处方总数的99.8%、99.5%、91.8%和94.5%。由开处方者签名的处方占96.2%,但只有75.8%的开处方者写了自己的名字。仅4.8%的配药人员印有自己的名字,32.7%的处方由药师签名。患者护理指标低于标准。结论:大多数处方不完整,处方医师远比配药人员完成了他们的角色。卫生设施有标准的处方纸和最新的药品清单。接触抗生素的百分比、按通用名称开处方的百分比和患者护理指标偏离标准。配药和咨询的时间也远不标准,而且大多数药物没有标签。
{"title":"Evaluation of Medicine-Use Pattern Using World Health Organization's Core Drug-Use Indicators and Completeness of Prescription at University of Gondar Comprehensive Specialized Hospital, Gondar, Ethiopia: Cross-Sectional Study.","authors":"Kefyalew Ayalew Getahun,&nbsp;Adugnaw Sitotie Redia,&nbsp;Tezera Jemere Aragaw","doi":"10.2147/IPRP.S261320","DOIUrl":"https://doi.org/10.2147/IPRP.S261320","url":null,"abstract":"<p><strong>Background: </strong>Rational use of medicines is patients receiving medicines appropriate to their diagnosis in doses that meet their requirements for an adequate period of time at an affordable price. Irrational prescribing practices result in ineffective, unsafe treatment, prolong prognosis, and increase health-care costs, and this is a common phenomenon in Ethiopia. The aim of this study was to evaluate medicine-use pattern using World Health Organization core drug-use indicators and completeness of prescription at the University of Gondar Comprehensive Specialized Hospital.</p><p><strong>Methods: </strong>A retrospective and prospective cross-sectional descriptive study was conducted at the dispensing pharmacy units of the health facility from March 2019 to May 2019 using a systematic random sampling technique. Data were analyzed using SPSS version 24.0, and results are presented using tables.</p><p><strong>Results: </strong>A total of 1,128 medicines were covered in the analyzed sample. The response rate, using standard prescription paper was found to be 100%. Mean number of medicines per prescription was 1.88. The proportion of medicines actually dispensed was 74.56%, and 91.4% medicines were prescribed by their generic names. Among prescribed medicines, antibiotics accounted for 37.5%, and 20% of the prescribed medicines were injectable. Prescriptions containing patient name, identification number, age, and sex comprised 99.8%, 99.5%, 91.8%, and 94.5%, respectively of the total. Prescriptions signed by prescribers accounted for 96.2%, however, only 75.8% of prescribers wrote their name. Moreover, only 4.8% of dispensers printed their name, and 32.7% of prescriptions were signed by pharmacists. Patient-care indicators were found to be below standard.</p><p><strong>Conclusion: </strong>Most prescriptions were incomplete, and prescribers by far completed their role than dispensers. The health facility has standard prescription paper and updated pharmaceuticals list. Percentages for encounters with antibiotics, prescribing by generic name, and patient-care indicators deviated from the standard. The dispensing and counseling time also far from the standard, and most medicines were not labeled.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"9 ","pages":"219-227"},"PeriodicalIF":2.9,"publicationDate":"2020-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/IPRP.S261320","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38545087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Magnitude, Nature, and Risk Factors of Adverse Drug Reactions Associated with First Generation Antipsychotics in Outpatients with Schizophrenia: A Cross-Sectional Study. 与精神分裂症门诊患者使用第一代抗精神病药物相关的药物不良反应的程度、性质和风险因素:一项横断面研究
IF 2.9 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-14 eCollection Date: 2020-01-01 DOI: 10.2147/IPRP.S271814
Merhawi Bahta, Tzeggai Berhe, Mulugeta Russom, Eyasu H Tesfamariam, Azieb Ogbaghebriel

Background: ADRs to antipsychotics are amongst the major challenges in the treatment of patients with psychotic disorders. The extent of patient-reported ADRs assessed in many studies using standardized scales is found to be inconsistent. However, there is a paucity of such research in Eritrea. The aim of the study is therefore to determine the magnitude, nature, and the possible risk factors associated with ADRs of the first generation antipsychotics in outpatients with schizophrenia at Saint Mary Neuro-Psychiatric National Referral Hospital in Asmara, Eritrea, using the LUNSERS self-rating scale.

Methods: A cross-sectional, descriptive and analytical study design utilizing a quantitative approach was employed. Data were collected from patients' self-administered questionnaires, interviews, and medical records. The collected variables were analyzed using SPSS 22.0 with descriptive statistics, correlation, t-tests, ANOVA, and multiple regression. Statistical significance was tested at P-value<0.05.

Results: In this study, 93.8% of the research participants experienced at least one ADR. LUNSERS total mean score of the relevant items was 28.01 (SD=18.46) with 24.7% of the study participants scoring medium-to-high. The prevalence of the categories of ADRs was psychic (91.3%), autonomic (78.1%), extra-pyramidal (76.9%), miscellaneous (66.5%), hormonal (58.3%), anti-cholinergic (44.2%), and allergic reactions (44.2%). At multivariate level, factors significantly and positively associated with total ADR score were smoking (P=0.028) and being at secondary educational level (P=0.015).

Conclusion: There was high prevalence of ADRs with moderate-to-high overall ADR scores in a significant number of patients. The most frequently reported ADRs were psychic, autonomic, extra-pyramidal, hormonal, and miscellaneous. Smoking and secondary level of education were found to be the main determinants of ADRs.

背景:抗精神病药物的不良反应是治疗精神病患者的主要挑战之一。许多研究使用标准化量表对患者报告的不良反应程度进行了评估,但结果并不一致。然而,在厄立特里亚却鲜有此类研究。因此,本研究旨在使用 LUNSERS 自评量表确定厄立特里亚阿斯马拉圣玛丽神经精神病国家转诊医院门诊精神分裂症患者第一代抗精神病药物不良反应的程度、性质和可能的相关风险因素:采用横断面、描述性和分析性研究设计,使用定量方法。数据来自患者自填的问卷、访谈和病历。收集到的变量使用 SPSS 22.0 进行分析,包括描述性统计、相关性、t 检验、方差分析和多元回归。统计显著性以 P 值检验:在本研究中,93.8% 的研究参与者至少经历过一次 ADR。LUNSERS 相关项目的总平均分为 28.01(SD=18.46),24.7% 的研究参与者得分中等至高等。各类 ADR 的发生率分别为精神(91.3%)、自主神经(78.1%)、锥体外系(76.9%)、其他(66.5%)、激素(58.3%)、抗胆碱能(44.2%)和过敏反应(44.2%)。在多变量水平上,与 ADR 总分呈显著正相关的因素是吸烟(P=0.028)和中等教育水平(P=0.015):结论:大量患者的 ADR 发生率较高,ADR 总分处于中高水平。最常报告的 ADR 包括精神、自主神经、锥体外系、激素和其他。吸烟和中等教育水平被认为是 ADRs 的主要决定因素。
{"title":"Magnitude, Nature, and Risk Factors of Adverse Drug Reactions Associated with First Generation Antipsychotics in Outpatients with Schizophrenia: A Cross-Sectional Study.","authors":"Merhawi Bahta, Tzeggai Berhe, Mulugeta Russom, Eyasu H Tesfamariam, Azieb Ogbaghebriel","doi":"10.2147/IPRP.S271814","DOIUrl":"10.2147/IPRP.S271814","url":null,"abstract":"<p><strong>Background: </strong>ADRs to antipsychotics are amongst the major challenges in the treatment of patients with psychotic disorders. The extent of patient-reported ADRs assessed in many studies using standardized scales is found to be inconsistent. However, there is a paucity of such research in Eritrea. The aim of the study is therefore to determine the magnitude, nature, and the possible risk factors associated with ADRs of the first generation antipsychotics in outpatients with schizophrenia at Saint Mary Neuro-Psychiatric National Referral Hospital in Asmara, Eritrea, using the LUNSERS self-rating scale.</p><p><strong>Methods: </strong>A cross-sectional, descriptive and analytical study design utilizing a quantitative approach was employed. Data were collected from patients' self-administered questionnaires, interviews, and medical records. The collected variables were analyzed using SPSS 22.0 with descriptive statistics, correlation, t-tests, ANOVA, and multiple regression. Statistical significance was tested at <i>P</i>-value<0.05.</p><p><strong>Results: </strong>In this study, 93.8% of the research participants experienced at least one ADR. LUNSERS total mean score of the relevant items was 28.01 (SD=18.46) with 24.7% of the study participants scoring medium-to-high. The prevalence of the categories of ADRs was psychic (91.3%), autonomic (78.1%), extra-pyramidal (76.9%), miscellaneous (66.5%), hormonal (58.3%), anti-cholinergic (44.2%), and allergic reactions (44.2%). At multivariate level, factors significantly and positively associated with total ADR score were smoking (<i>P</i>=0.028) and being at secondary educational level (<i>P</i>=0.015).</p><p><strong>Conclusion: </strong>There was high prevalence of ADRs with moderate-to-high overall ADR scores in a significant number of patients. The most frequently reported ADRs were psychic, autonomic, extra-pyramidal, hormonal, and miscellaneous. Smoking and secondary level of education were found to be the main determinants of ADRs.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"9 ","pages":"205-217"},"PeriodicalIF":2.9,"publicationDate":"2020-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/17/ff/iprp-9-205.PMC7569056.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38636265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hospital-Wide Medication Reconciliation Program: Error Identification, Cost-Effectiveness, and Detecting High-Risk Individuals on Admission. 全院范围内的药物和解计划:错误识别,成本效益,并在入院时检测高风险个体。
IF 2.9 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-13 eCollection Date: 2020-01-01 DOI: 10.2147/IPRP.S269857
Dustin J Uhlenhopp, Oscar Aguilar, Dong Dai, Arka Ghosh, Michael Shaw, Chandan Mitra

Background: Medication reconciliation (MR) on admission has potential to reduce negative patient outcomes. The objectives of this prospective observational study were to 1) measure the impact a hospital-wide MR program has on home medication error identification at hospital admission, 2) demonstrate cost-effectiveness of this program, and 3) identify risk factors placing individual patients at higher risk for medication discrepancies.

Methods: Technicians obtained medication histories on adult patients admitted to the hospital that managed their own medications. Frequency and type of medication errors were recorded. Cost avoidance estimations were determined based on expected adverse drug event rates. Logistic regression analysis was used to test for associations between medication errors and patient characteristics. Results were considered significant when p-value was less than 0.05.

Results: The study included 817 patients. Technicians recorded a mean of 6.1 medication discrepancies per patient (SD ± 0.4) and took 28.5 minutes (SD ± 1.2 minutes) to complete a medication history. Omission, commission, and dosing/frequency errors occurred in 82%, 59%, and 50% of medication histories, respectively. We estimated cost avoidance of $210.33 per patient with this program. Female gender, age, and high alert/risk medication use were linked to an increase in the likelihood of occurrence of a medication discrepancy.

Conclusion: This study validated the ability of a pharmacy technician to identify errors, demonstrated economic cost-effectiveness, provided new data on time to obtain a BPMH, and further identified factors that contribute to the occurrence of medication discrepancies. Potentially harmful medication discrepancies were identified frequently on admission. With further research, it may be possible to identify those at highest risk for home medication discrepancies upon admission.

背景:入院时的药物调解(MR)有可能减少患者的负面结果。这项前瞻性观察性研究的目的是:1)衡量全院范围内的磁共振项目对入院时家庭用药错误识别的影响;2)证明该项目的成本效益;3)确定使个体患者用药不一致风险更高的风险因素。方法:技术人员获取住院自行用药的成年患者的用药史。记录用药错误的频率和类型。成本避免估计是根据预期的药物不良事件发生率确定的。采用Logistic回归分析检验用药错误与患者特征之间的关系。当p值小于0.05时,认为结果显著。结果:纳入817例患者。技术人员平均记录每位患者6.1个用药差异(SD±0.4),耗时28.5分钟(SD±1.2分钟)完成用药史。遗漏、委托和剂量/频率错误分别发生在82%、59%和50%的用药史中。我们估计使用该方案可为每位患者节省210.33美元的费用。女性性别、年龄和高警戒/高风险药物使用与药物差异发生的可能性增加有关。结论:本研究验证了药学技术人员识别错误的能力,证明了经济成本效益,及时提供了获得BPMH的新数据,并进一步确定了导致用药差异发生的因素。潜在有害的用药差异在入院时经常被发现。通过进一步的研究,有可能在入院时识别出家庭用药差异风险最高的患者。
{"title":"Hospital-Wide Medication Reconciliation Program: Error Identification, Cost-Effectiveness, and Detecting High-Risk Individuals on Admission.","authors":"Dustin J Uhlenhopp,&nbsp;Oscar Aguilar,&nbsp;Dong Dai,&nbsp;Arka Ghosh,&nbsp;Michael Shaw,&nbsp;Chandan Mitra","doi":"10.2147/IPRP.S269857","DOIUrl":"https://doi.org/10.2147/IPRP.S269857","url":null,"abstract":"<p><strong>Background: </strong>Medication reconciliation (MR) on admission has potential to reduce negative patient outcomes. The objectives of this prospective observational study were to 1) measure the impact a hospital-wide MR program has on home medication error identification at hospital admission, 2) demonstrate cost-effectiveness of this program, and 3) identify risk factors placing individual patients at higher risk for medication discrepancies.</p><p><strong>Methods: </strong>Technicians obtained medication histories on adult patients admitted to the hospital that managed their own medications. Frequency and type of medication errors were recorded. Cost avoidance estimations were determined based on expected adverse drug event rates. Logistic regression analysis was used to test for associations between medication errors and patient characteristics. Results were considered significant when p-value was less than 0.05.</p><p><strong>Results: </strong>The study included 817 patients. Technicians recorded a mean of 6.1 medication discrepancies per patient (SD ± 0.4) and took 28.5 minutes (SD ± 1.2 minutes) to complete a medication history. Omission, commission, and dosing/frequency errors occurred in 82%, 59%, and 50% of medication histories, respectively. We estimated cost avoidance of $210.33 per patient with this program. Female gender, age, and high alert/risk medication use were linked to an increase in the likelihood of occurrence of a medication discrepancy.</p><p><strong>Conclusion: </strong>This study validated the ability of a pharmacy technician to identify errors, demonstrated economic cost-effectiveness, provided new data on time to obtain a BPMH, and further identified factors that contribute to the occurrence of medication discrepancies. Potentially harmful medication discrepancies were identified frequently on admission. With further research, it may be possible to identify those at highest risk for home medication discrepancies upon admission.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"9 ","pages":"195-203"},"PeriodicalIF":2.9,"publicationDate":"2020-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/IPRP.S269857","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38636264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Effect of Auditable Pharmaceutical Services and Transaction System on Pharmaceutical Service Outcomes in Public Hospitals of SNNPR, Ethiopia. 埃塞俄比亚SNNPR公立医院药学服务审计与交易制度对药学服务效果的影响
IF 2.9 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2020-10-13 eCollection Date: 2020-01-01 DOI: 10.2147/IPRP.S277080
Deginet Beyene, Habtamu Abuye, Gizachew Tilahun

Background: Auditable pharmaceuticals service and transaction system (APTS) is unique in its systems strengthening approach. It is a data-driven package of interventions designed to establish accountable, transparent, and responsible pharmacy practice. The objective of this study was to assess the outcome performance of pharmaceuticals services among selected hospitals with and without the APTS system in SNNPR, Ethiopia.

Methods: A cross-sectional comparative facility-based study was conducted at public hospitals by using an intervention and control approach to estimate the significance of the difference between average performances of APTS and non-APTS hospitals. A case-to-control ratio was applied to decide the number of sites and a simple random lottery sampling technique was employed to select control sites. The sample size formula was used to determine the proposed population for patient care indicator assessment. Epidata version 3.1 and SPSS version 23 were used for analysis. The study was conducted from March 1 to 30, 2019.

Results: APTS implemented hospitals attained 92.3% patient satisfaction on the overall pharmacy services compared to 47.5% for non-APTS hospitals. They have improved essential drugs (EDs) availability, minimum stock-outs, and reduced wastage rates, unlike control groups. They undertook workload analysis to assess human power sufficiency; generate reliable information from accurate recording culture for decision making; practiced transparency and accountability through conducting physical inventory and daily sales tracking/management system; and made budget utilization rationale applying ABC analysis, VEN analysis, ABC/VEN reconciliation, and stock status analysis (SSA) that non-APTS hospitals did less/not.

Conclusion: In general, higher performances were observed in APTS implemented hospitals than non-APTS hospitals regarding patient knowledge, satisfaction, and medicine availability at stores. In all cases, it needs improvement to achieve target values.

背景:可审计药品服务和交易系统(APTS)在其系统强化方法上是独一无二的。这是一套数据驱动的干预措施,旨在建立负责任、透明和负责任的药房实践。本研究的目的是评估在埃塞俄比亚SNNPR有和没有APTS系统的选定医院中药品服务的结果表现。方法:采用干预对照法对公立医院进行横断面比较研究,评估APTS医院与非APTS医院平均绩效差异的显著性。采用病例与对照比来确定站点数量,采用简单的随机摇号抽样技术来选择对照站点。样本量公式用于确定患者护理指标评估的建议人群。采用Epidata 3.1版和SPSS 23版进行分析。该研究于2019年3月1日至30日进行。结果:实施APTS的医院对整体药房服务的满意度为92.3%,而非实施APTS的医院为47.5%。与对照组不同,他们改善了基本药物的可得性,减少了缺货,并降低了浪费率。他们进行工作量分析,以评估人力是否充足;从准确的记录文化中产生可靠的信息,用于决策;实行透明度和问责制,通过实施实物库存和日常销售跟踪/管理系统;并运用ABC分析、VEN分析、ABC/VEN对账、库存状况分析(SSA)对非apts医院较少/不较少的预算利用进行论证。结论:总体而言,实施APTS的医院在患者知识、满意度和药品库存方面的表现优于非实施APTS的医院。在所有情况下,都需要改进才能达到目标值。
{"title":"Effect of Auditable Pharmaceutical Services and Transaction System on Pharmaceutical Service Outcomes in Public Hospitals of SNNPR, Ethiopia.","authors":"Deginet Beyene,&nbsp;Habtamu Abuye,&nbsp;Gizachew Tilahun","doi":"10.2147/IPRP.S277080","DOIUrl":"https://doi.org/10.2147/IPRP.S277080","url":null,"abstract":"<p><strong>Background: </strong>Auditable pharmaceuticals service and transaction system (APTS) is unique in its systems strengthening approach. It is a data-driven package of interventions designed to establish accountable, transparent, and responsible pharmacy practice. The objective of this study was to assess the outcome performance of pharmaceuticals services among selected hospitals with and without the APTS system in SNNPR, Ethiopia.</p><p><strong>Methods: </strong>A cross-sectional comparative facility-based study was conducted at public hospitals by using an intervention and control approach to estimate the significance of the difference between average performances of APTS and non-APTS hospitals. A case-to-control ratio was applied to decide the number of sites and a simple random lottery sampling technique was employed to select control sites. The sample size formula was used to determine the proposed population for patient care indicator assessment. Epidata version 3.1 and SPSS version 23 were used for analysis. The study was conducted from March 1 to 30, 2019.</p><p><strong>Results: </strong>APTS implemented hospitals attained 92.3% patient satisfaction on the overall pharmacy services compared to 47.5% for non-APTS hospitals. They have improved essential drugs (EDs) availability, minimum stock-outs, and reduced wastage rates, unlike control groups. They undertook workload analysis to assess human power sufficiency; generate reliable information from accurate recording culture for decision making; practiced transparency and accountability through conducting physical inventory and daily sales tracking/management system; and made budget utilization rationale applying ABC analysis, VEN analysis, ABC/VEN reconciliation, and stock status analysis (SSA) that non-APTS hospitals did less/not.</p><p><strong>Conclusion: </strong>In general, higher performances were observed in APTS implemented hospitals than non-APTS hospitals regarding patient knowledge, satisfaction, and medicine availability at stores. In all cases, it needs improvement to achieve target values.</p>","PeriodicalId":45655,"journal":{"name":"Integrated Pharmacy Research and Practice","volume":"9 ","pages":"185-194"},"PeriodicalIF":2.9,"publicationDate":"2020-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/IPRP.S277080","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38635861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Integrated Pharmacy Research and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1